According to Grifols's latest financial reports the company's total assets are $23.70 B. A companyโs total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.
Year | Total assets | Change |
---|---|---|
2022-12-31 | $23.06 B | 5.88% |
2021-12-31 | $21.78 B | 15.94% |
2020-12-31 | $18.78 B | 7.91% |
2019-12-31 | $17.41 B | 21.98% |
2018-12-31 | $14.27 B | 8.88% |
2017-12-31 | $13.10 B | 22.94% |
2016-12-31 | $10.66 B | 1.57% |
2015-12-31 | $10.49 B | 2.16% |
2014-12-31 | $10.27 B | 27.4% |
2013-12-31 | $8.06 B | 8.36% |
2012-12-31 | $7.44 B | 1.84% |
2011-12-31 | $7.30 B | 190.92% |
2010-12-31 | $2.51 B | 5.83% |
2009-12-31 | $2.37 B | 43.9% |
2008-12-31 | $1.64 B | 20.27% |
2007-12-31 | $1.37 B | 13.59% |
2006-12-31 | $1.20 B | 24.39% |
2005-12-31 | $0.97 B |
Company | Total assets | differencediff. | Country |
---|---|---|---|
Johnson & Johnson JNJ | $171.96 B | 625.44% | ๐บ๐ธ USA |
Amgen AMGN | $97.15 B | 309.85% | ๐บ๐ธ USA |
Baxter BAX | $27.78 B | 17.22% | ๐บ๐ธ USA |
Kimberly-Clark KMB | $17.09 B | -27.90% | ๐บ๐ธ USA |